Veterinary Renal Disease Market Size, Share & Trends Analysis Report By Type (Diagnosis, Treatment), By Animal Type (Canine, Feline, Bovine, Equine, Others), By Route of Administration (Oral, Injectable), By Indication  (Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Others), By Distribution Channel (Veterinary Hospitals & Clinics, Pet Specialty Stores, E-Commerce, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Veterinary Renal Disease Market Size

The global veterinary renal disease market size was valued at USD 16.69 billion in 2024 and is projected to grow from USD 17.73 billion in 2025 to reach USD 26.12 billion by 2033, exhibiting a CAGR of 4.9% during the forecast period (2025-2033).

Veterinary renal disease encompasses a range of kidney disorders affecting animals, including pets, livestock, and wildlife. The kidneys are essential for filtering waste products, regulating fluid balance, and maintaining vital functions in animals. Renal diseases vary from acute kidney injury (AKI) to chronic kidney disease (CKD), with CKD being particularly prevalent in older pets, especially cats and dogs.

Early diagnosis and treatment are critical for managing disease progression, as untreated conditions can lead to kidney failure. Treatment strategies typically include dietary changes, medications, and, in severe cases, dialysis or kidney transplantation. The market is experiencing significant growth, driven by the rising incidence of renal complications in animals, including conditions like kidney stones and cystitis. A growing focus on pet foods designed to treat renal diseases also contributes to market demand.

Moreover, enhanced awareness campaigns and advances in diagnostic techniques, such as blood tests, urinalysis, radiography, and abdominal ultrasounds, have improved the detection of kidney dysfunction in animals. The increasing prevalence of renal diseases in companion animals, particularly cats and dogs, further propels the demand for effective treatments and diagnostic solutions. As awareness grows and diagnostic capabilities improve, the veterinary renal disease market is poised for continued growth.

Veterinary Renal Disease Market Trends

Increased use of specialized pet foods

As awareness of renal diseases in animals grows, there is an increasing demand for specialized diets that support kidney health and manage existing disorders. Veterinary professionals are increasingly recommending tailored pet foods designed to help manage and even prevent kidney conditions.

• For instance, a July 2023 article published by the Veterinary Information Network emphasized the significant role dietary therapy plays in reducing the risk of renal diseases in dogs by up to 69%.

This growing awareness is driving the demand for specialized diets that help manage kidney disorders, thus contributing to the expansion of the veterinary renal disease market.

Growing recognition of urinary and renal issues in animals

The rising recognition of urinary and renal issues in animals has led to an increased need for diagnostic and therapeutic solutions. More veterinarians are focusing on early detection and tailored treatments for kidney-related conditions.

• For instance, in June 2024, the International Renal Interest Society released new guidelines on diagnosing and managing Acute Kidney Injury (AKI), focusing on early detection, monitoring risk factors, and offering personalized treatment to prevent complications.

This heightened awareness of renal diseases is fueling the demand for advanced diagnostic equipment and therapies, further propelling the growth of the market.

Veterinary Renal Disease Market Drivers

High prevalence of chronic kidney disease (CKD) in companion animals

The rising incidence of Chronic Kidney Disease (CKD) in companion animals, particularly dogs and cats, is one of the key factors driving the growth of the market. CKD has become a significant health concern for pets, especially as they age, leading to a growing demand for advanced diagnostics and treatments.

For instance,

• A September 2024 report by the MSD Veterinary Manual revealed that up to 10% of dogs and 35% of cats at referral centers suffer from CKD, with the general small animal population showing an estimated incidence of 1%–3%.
• Likewise, a study by the Minnesota Urolith Center in November 2024 found that a significant portion of over 45,000 cats evaluated between 2022-2023 were diagnosed with kidney stones, further highlighting the rising prevalence of kidney-related issues.

The high prevalence of CKD is driving demand for innovative diagnostic tools, treatments, and specialized pet foods, thus contributing significantly to the growth of the veterinary renal disease market.

Industry collaboration and charitable initiatives

Collaboration between industry players and charitable organizations is a significant driver of the market. These partnerships are focusing on improving the availability of veterinary care and increasing access to treatment for pets in need.

• For instance, in January 2023, Purina Pro Plan Veterinary Diets collaborated with the American Veterinary Medical Foundation (AVMF) to support the REACH program, contributing up to $200,000 to assist veterinarians in providing care for economically disadvantaged pet owners.

These charitable initiatives and collaborations not only support veterinarians in offering quality care to pets from underserved communities but also promote the adoption of effective treatments for renal diseases.

Market Restraining Factors

High cost associated with diagnosing and treating renal diseases in animals

The high costs of diagnosing and treating renal diseases in animals pose a significant challenge to the market, particularly in less developed countries or among pet owners with limited financial resources. The expense of advanced treatments, such as dialysis, specialized diets, and ongoing medical care for renal failure, can be prohibitively expensive. This financial burden, combined with a lack of awareness and information regarding kidney diseases in pets, limits access to essential treatments and hampers market growth. Consequently, many pet owners cannot provide the necessary care, restricting the demand for renal disease solutions.

Market Opportunity

Increasing veterinary care accessibility

The expanding accessibility of veterinary care is a major opportunity for the veterinary renal disease market, driven by rising pet ownership and higher spending on pet health. As more families prioritize the well-being of their pets, there is a growing demand for affordable and comprehensive veterinary services.

• For example, according to the American Pet Products Association (APPA), the U.S. pet industry is projected to reach $150.6 billion in 2024, reflecting a steady increase in pet ownership, with 82 million households owning pets.

This surge in pet ownership presents a significant opportunity for veterinary care providers to reach a broader customer base, enhance the availability of services, and innovate in pet healthcare solutions.

Regional Insights

North America: Dominant region with 40.5% market share

North America maintains its leadership in the global veterinary renal disease market, largely driven by high pet ownership, substantial spending on pet healthcare, and an advanced veterinary infrastructure. The region is home to numerous leading providers of veterinary care, equipped with state-of-the-art diagnostic systems and highly trained professionals, which has significantly boosted demand for veterinary hospitals and clinics.

Moreover, government initiatives aimed at controlling zoonotic diseases have fostered increased investments in veterinary care, further accelerating market growth. The region's growing awareness of pet health and increasing emphasis on preventive care contribute to North America's dominance in the market, establishing it as a key player in the global veterinary renal disease landscape.

Asia Pacific: Fastest growing region with the highest market CAGR

Asia-Pacific is poised to experience the highest market CAGR in the veterinary renal disease sector during the forecast period. This growth is largely driven by an expanding pet population, increasing disposable income, and urbanization, which have raised the demand for high-quality veterinary services. Key countries like China, India, and Australia are witnessing a surge in pet ownership, and as a result, there is a greater focus on improving veterinary care infrastructure. Moreover, the rising incidence of zoonotic diseases in the region has highlighted the importance of robust veterinary diagnostic and treatment centers.

Countries Insights

• U.S.– The U.S. leads the veterinary renal disease industry, driven by the highest pet ownership rates globally and substantial spending on pet healthcare. In 2022, the American Pet Products Association (APPA) reported that U.S. pet care expenditures reached $136.8 billion, with a significant share allocated to veterinary services. This high level of investment in pet health services, coupled with increasing awareness of renal diseases in pets, has resulted in greater demand for specialized treatments and diagnostic solutions, propelling market growth in the country.
• Germany- Germany remains one of the largest markets for veterinary renal disease in Europe, supported by robust animal welfare regulations and a well-established network of veterinary clinics and hospitals. The German Federal Ministry of Food and Agriculture plays a key role in promoting animal health initiatives, encouraging the expansion of modern veterinary facilities. This framework, alongside an increasing focus on pet healthcare, contributes to the growth of the veterinary renal disease market by enhancing access to advanced diagnostic and treatment options.
• China - China’s market is expanding rapidly due to rising urbanization, increasing disposable incomes, and a growing pet population. By 2023, China had approximately 120 million pet dogs and cats, fueling demand for veterinary care services. As pet ownership rises, so does the need for advanced healthcare options, including renal disease diagnosis and treatment. This market growth is further supported by the government’s efforts to improve pet welfare and increase awareness of the importance of veterinary care in the country.
• France– France’s market for veterinary renal disease is growing due to rising pet ownership and increased health consciousness among pet owners. Advances in diagnostic tools and treatment options have made it easier to detect and manage chronic kidney disease in aging pets. The increasing prevalence of renal conditions, along with a growing focus on preventive care and overall pet health, has spurred greater demand for specialized veterinary services. As a result, France’s market is experiencing steady growth in response to these trends.
• India– India is witnessing rapid growth in the market for affairs related to veterinary renal disease, aided by increasing population and awareness toward pet health care. For instance, in October 2024, a retrospective study spanning a decade, published in the Indian Journal of Animal Sciences, reported canine renal insufficiency in Bihar, India. The study stressed that early diagnosis and supportive therapy should be given foremost priority in the effective management of renal dysfunction, consequently supplementing the growth of the country's market.
• Saudi Arabia- Saudi Arabia's market is experiencing strong growth due to increasing demand for enhanced veterinary care, including modern diagnostic and therapeutic options. The Saudi government has committed to expanding the veterinary healthcare sector, focusing on improving pet care infrastructure and promoting awareness of renal diseases in pets. As the incidence of renal diseases in pets rises, these efforts are driving the market’s growth, with both private and public sectors playing a pivotal role in advancing veterinary healthcare in the region.

Segmentation Analysis

The global veterinary renal disease market is segmented into type, animal type, route of administration, indication, and distribution channel.

By Type

The treatment segment leads the market, generating the highest market revenue due to the increasing prevalence of renal diseases in animals and the growing demand for effective treatments.

• For example, in September 2024, the MSD Vet Manual highlighted the use of antibiotics, antifungals, cystine-binding agents, and diuretics in treating kidney and urinary tract diseases in animals.

This demand for targeted and efficient treatments solidifies the treatment segment's dominance and drives market development, ensuring better therapeutic options for animal renal health.

By Animal Type

The feline segment holds the largest market share in the market for veterinary renal disease. Cats are particularly vulnerable to renal diseases, with genetic, physiological, and behavioral factors increasing their susceptibility, especially to chronic kidney disease (CKD). This heightened risk of renal issues in cats has spurred the demand for specialized diagnostics, treatments, and tailored diets. As a result, felines dominate the market, highlighting the need for advanced renal health solutions specific to their unique needs.

By Route of Administration

The oral segment dominates the market, driven by the preference for oral administration of therapeutic foods. Oral treatments are less stressful for pets and owners compared to injections, and they offer a convenient way to manage chronic conditions. The widespread use of oral supplements, particularly in the treatment of renal diseases, contributes to improved treatment outcomes, making oral administration a more accessible and effective option for both veterinarians and pet owners, facilitating market growth.

By Indication

Renal cystitis holds the largest market share in the market for veterinary renal disease due to its high prevalence in companion animals. A study published in October 2023 in the Benha Veterinary Medical Journal reported that chronic cystitis affected 48.1% of dogs and 30.7% of cats. This widespread occurrence of renal cystitis necessitates frequent diagnostic and therapeutic interventions, driving the market demand for specialized treatments and reinforcing the prominence of the renal cystitis segment in the market.

By Distribution Channel

Veterinary hospitals and clinics dominate the market, as pet owners typically seek professional medical care and specialized treatment for conditions like kidney disorders. These facilities play a crucial role in providing comprehensive veterinary services, from diagnosis and monitoring to ongoing treatment for conditions such as CKD and renal cystitis. Veterinary hospitals and clinics offer advanced diagnostic tools, including blood tests, urinalysis, and imaging, alongside specialized treatment plans tailored to each pet’s needs.

Company Market Share

Key players in the veterinary renal disease market are increasingly focusing on adopting a variety of strategic business approaches to strengthen their market position. These strategies include strategic collaborations with research institutions, veterinary clinics, and other stakeholders to enhance their product offerings and expand their reach.

Nestle Purina Pet Care: An emerging player in the market

Nestlé Purina Pet Care uses its pet nutrition expertise and strong global presence to dominate the market. This company can sustain competition as it takes big investments in R&D that entail creative solutions to control renal diseases.

Recent developments by Nestle Purina Pet Care:

• In August 2024, The U.S. Food and Drug Administration (FDA) wrapped up its investigation into the cases involving Nestlé Purina Pet Care pet food and confirmed that there were no health risks to consumers based on the product.

Recent Developments

• January 2024 –Zoetis Services LLC announced that AI urine sediment analysis was added to Vetscan Imagyst, its multi-application diagnostics platform. Clinicians will be able to make treatment decisions more rapidly, allowing for precise in-clinic sediment analysis of fresh urine.

Analyst Opinion

As per our analyst, the global veterinary renal disease market is on track for impressive growth, driven by factors such as an increase in pet ownership, rising awareness of pet health, and advancements in diagnostic technologies. The growing prevalence of renal disorders among older pets, combined with improvements in veterinary healthcare infrastructure, has significantly boosted the demand for effective treatments.

Moreover, as disposable income rises and the trend of humanizing pets continues to gain momentum, spending on pet healthcare is witnessing an upward trajectory. Despite the promising outlook, there are challenges that could impact market growth. The high cost of veterinary treatments, particularly for renal diseases, may limit access for some pet owners, especially in emerging markets.

Nevertheless, the continuous innovation in therapeutics and diagnostic technologies, alongside ongoing research and development in the field, offers immense potential to overcome these challenges. This makes the market one of the most dynamic and exciting areas in veterinary healthcare. As the market evolves, addressing these challenges will be crucial to ensure continued growth and accessibility for pet owners globally.